2019
DOI: 10.1016/j.bbr.2019.111981
|View full text |Cite
|
Sign up to set email alerts
|

Anxiety-like behavior induced by 6-OHDA animal model of Parkinson’s disease may be related to a dysregulation of neurotransmitter systems in brain areas related to anxiety

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
22
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 44 publications
(30 citation statements)
references
References 37 publications
2
22
0
Order By: Relevance
“…Similarly, other areas with sparse noradrenergic innervation, as the striatum, show unchanged or lower NA levels (Shin et al, 2014;Ostock et al, 2018). Bilateral models of 6-OHDA show, however, more robust NA deficits in the cortex and striatum (Vieira et al, 2019). 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated monkeys exhibit clear noradrenergic damage, including LC cell loss, lower NA concentrations in several brain regions, and reduced noradrenergic innervation of the SNc and the subthalamic nucleus (Pifl et al, 1991;Masilamoni et al, 2017).…”
Section: Preclinical Evidencementioning
confidence: 99%
See 1 more Smart Citation
“…Similarly, other areas with sparse noradrenergic innervation, as the striatum, show unchanged or lower NA levels (Shin et al, 2014;Ostock et al, 2018). Bilateral models of 6-OHDA show, however, more robust NA deficits in the cortex and striatum (Vieira et al, 2019). 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated monkeys exhibit clear noradrenergic damage, including LC cell loss, lower NA concentrations in several brain regions, and reduced noradrenergic innervation of the SNc and the subthalamic nucleus (Pifl et al, 1991;Masilamoni et al, 2017).…”
Section: Preclinical Evidencementioning
confidence: 99%
“…At the behavioral level, regardless inconsistencies found through the scientific publications, p a r k i n s o n i a n a n i m a l s t e n d t o m i m i c t h e h u m a n symptomatology showing motor but also non-motor impairments (Titova et al, 2017). An array of studies report that rodents lesioned with 6-OHDA or MPTP show anxious and depressive behavior, pain, cognitive, and sleep disturbances (Monaca et al, 2004;Pérez et al, 2009;Berghauzen-Maciejewska et al, 2014;Vo et al, 2014;Kamińska et al, 2017;Charles et al, 2018;Campos et al, 2019;Domenici et al, 2019), more notably in bilateral models of the disease (Ferro et al, 2005;Tadaiesky et al, 2008;Santiago et al, 2010;Bonito-Oliva et al, 2014;Vieira et al, 2019). Although the participation of other nuclei cannot be ruled out, the role of the LC in the mentioned functions is widely accepted.…”
Section: Preclinical Evidencementioning
confidence: 99%
“…The neurotoxin 6-OHDA is commonly used to selectively destroy dopaminergic neurons and is therefore often used to establish Parkinson's disease models. 18 The rats in the sham group (n = 10) were injected with 1 μL saline into the vPAG using the same procedure. All rats were allowed two weeks to recover before subsequent experiments.…”
Section: Lesions In the Vpagmentioning
confidence: 99%
“…Brain slices were constantly perfused with artificial cerebrospinal fluid (ACSF) saturated with 95% O 2 and 5% CO 2 at room temperature. The vPAG neurons were visually identified using a BX51WI microscope (Olympus) equipped with infrared-differential interference contrast optics, as described previously (18)…”
Section: Electrophysiologymentioning
confidence: 99%
See 1 more Smart Citation